ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,487.03
0.25%
Dow Jones
38,834.86
0.15%
US Dollar vs MXN
18.39
-0.13%
Brent Oil
84.48
-0.36%
Bitcoin
65,200.53
0.09%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Fibrocell Science Inc (FCSC)

  7. Fibrocell Science Inc (FCSC) Noticias

FCSC

Fibrocell Science (FCSC)

Fibrocell Science Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:FCSC
FechaHoraFuenteTítuloSímboloCompañía
07/01/202009:30Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:FCSCFibrocell Science Inc
18/12/201905:01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:FCSCFibrocell Science Inc
17/12/201916:59Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FCSCFibrocell Science Inc
13/12/201915:07Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:FCSCFibrocell Science Inc
13/12/201915:04Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:FCSCFibrocell Science Inc
13/12/201908:41Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:FCSCFibrocell Science Inc
13/12/201908:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:FCSCFibrocell Science Inc
22/11/201905:01Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:FCSCFibrocell Science Inc
14/11/201915:23Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:FCSCFibrocell Science Inc
28/10/201915:04Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (definitive) (defm14a)NASDAQ:FCSCFibrocell Science Inc
25/10/201917:00PR Newswire (US)SHAREHOLDER ALERT: WeissLaw LLP Investigates Fibrocell Science, Inc.NASDAQ:FCSCFibrocell Science Inc
11/10/201915:52Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (preliminary) (prem14a)NASDAQ:FCSCFibrocell Science Inc
25/09/201915:33Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:FCSCFibrocell Science Inc
17/09/201915:34Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:FCSCFibrocell Science Inc
12/09/201917:35PR Newswire (US)Castle Creek Pharmaceutical Holdings Announces Agreement to Acquire FibrocellNASDAQ:FCSCFibrocell Science Inc
12/09/201916:40GlobeNewswire Inc.Castle Creek Pharmaceutical Holdings to Acquire FibrocellNASDAQ:FCSCFibrocell Science Inc
29/08/201915:53Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:FCSCFibrocell Science Inc
14/08/201915:45GlobeNewswire Inc.Fibrocell Reports Second Quarter 2019 Financial Results and Recent Operational HighlightsNASDAQ:FCSCFibrocell Science Inc
30/05/201907:00GlobeNewswire Inc.Fibrocell to Present at BIO International Convention 2019NASDAQ:FCSCFibrocell Science Inc
29/05/201907:00GlobeNewswire Inc.Fibrocell Receives FDA Regenerative Medicine Advanced Therapy Designation for FCX-007 Gene Therapy for the Treatment of RDEBNASDAQ:FCSCFibrocell Science Inc
15/05/201906:30GlobeNewswire Inc.Fibrocell Reports First Quarter 2019 Financial Results and Recent Operational HighlightsNASDAQ:FCSCFibrocell Science Inc
09/05/201907:00GlobeNewswire Inc.Fibrocell to Host Conference Call and Webcast on Wednesday, May 15, 2019 to Discuss First Quarter 2019 Financial Results and ...NASDAQ:FCSCFibrocell Science Inc
29/04/201915:22Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:FCSCFibrocell Science Inc
15/04/201905:30GlobeNewswire Inc.Fibrocell Announces Collaboration with Castle Creek Pharmaceuticals to Develop and Commercialize FCX-007 Gene TherapyNASDAQ:FCSCFibrocell Science Inc
03/04/201907:00GlobeNewswire Inc.Fibrocell Announces Board Member Christine St.Clare Honored by National Association of Corporate DirectorsNASDAQ:FCSCFibrocell Science Inc
27/03/201915:40Edgar (US Regulatory)Annual Report (10-k)NASDAQ:FCSCFibrocell Science Inc
27/03/201906:30GlobeNewswire Inc.Fibrocell Announces Positive Feedback from Type B End-of-Phase 2 Meeting with FDA on Phase 3 Clinical Trial Design for FCX-00...NASDAQ:FCSCFibrocell Science Inc
20/03/201907:00GlobeNewswire Inc.Fibrocell to Host Conference Call & Webcast for Full Year 2018 Financial Results and Recent Highlights on March 27, 2019NASDAQ:FCSCFibrocell Science Inc
14/02/201913:20Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:FCSCFibrocell Science Inc
06/02/201907:00GlobeNewswire Inc.Fibrocell to Present at 21st Annual BIO CEO & Investor ConferenceNASDAQ:FCSCFibrocell Science Inc
 Showing the most relevant articles for your search:NASDAQ:FCSC

Su Consulta Reciente

USOTC
DTEGY
Deutsche Telekom (QX)
NASDAQ
NVDA
NVIDIA
NASDAQ
MSFT
Microsoft
NASDAQ
QQQ
Invesco QQQ Trust Series 1
FX
EURMXN
Euro vs MXN
USOTC
BNPQY
BNP Paribas (QX)
SPI
SP500
S&P 500
NYSE
KO
Coca Cola
USOTC
RHHBY
Roche (QX)
PM
XAUUSD
Gold vs US Dollar
NYSE
VZ
Verizon Communications
NYSE
DIS
Walt Disney
NASDAQ
AMZN
Amazon.com
USI
USTECH100
US Tech 100
COIN
BTCUSD
Bitcoin
NYSE
BAC
Bank of America
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados